Aimmune Therapeutics, Inc. Business Finance Contracts & Agreements
18 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investor Rights Agreements (1)
- Purchase Agreements (3)
- Registration Rights Agreements (3)
- Stock Agreements (7)
- Underwriting Agreements (2)
- Form of Global Restricted Stock Unit Grant Notice and Award Agreement (Filed With SEC on July 31, 2020)
- Form of Global Stock Option Grant Notice and Award Agreement (Filed With SEC on July 31, 2020)
- Securities Purchase Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
- Amended and Restated Registration Rights Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
- Securities Purchase Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)
- Amended and Restated Registration Rights Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)
- Underwriting Agreement, dated as of February 21, 2018, among Aimmune Therapeutics, Inc. and Merrill, Lynch, Pierce, Fenner & Smith Incorporated, as representative of the... (Filed With SEC on February 26, 2018)
- AIMMUNE THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 15, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 15, 2017)
- AIMMUNE THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE,SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on July 27, 2015)
- Aimmune Therapeutics, Inc. Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 27, 2015)
- [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH... (Filed With SEC on July 6, 2015)
- ALLERGEN RESEARCH CORPORATION NOTICE OF GRANT OF RESTRICTED STOCK (Filed With SEC on July 6, 2015)
- ALLERGEN RESEARCH CORPORATION NOTICE OF GRANT OF STOCK OPTION (IMMEDIATELY EXERCISABLE) (Filed With SEC on July 6, 2015)
- AMENDMENT TO THE ALLERGEN RESEARCH CORPORATION 2013 STOCK PLAN EffectiveJanuary 20, 2015 (Filed With SEC on July 6, 2015)
- ALLERGEN RESEARCH CORPORATION AMENDED AND RESTATED 2013 STOCK PLAN TABLE OF CONTENTS (Filed With SEC on July 6, 2015)
- [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH... (Filed With SEC on July 6, 2015)
- AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on July 6, 2015)
